other_material
confidence high
sentiment positive
materiality 0.65
MIRA reports SKNY-1 achieves 30% weight loss and reverses cravings in zebrafish obesity model
MIRA PHARMACEUTICALS, INC.
- SKNY-1 reduced body weight by ~30% in six days; treated animals weighed ~10% less than healthy controls.
- Liver fat buildup reversed to healthy levels; cholesterol (LDL/HDL) normalized without disrupting metabolic balance.
- Obese animals ate 2-3x more high-calorie food; SKNY-1 dose-dependently reduced compulsive eating and food-seeking.
- Nicotine craving and seeking behavior significantly reduced; high-dose group matched healthy animal behavior.
- Leptin and ghrelin normalized; lower-dose SKNY-1 reduced elevated brain dopamine linked to reward cravings.
item 8.01